Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract International crises demand active formation of health research partnerships, which are collaborative relationships between two or more parties for the common goal of improving the health of populations through mutually agreed functions and principles and sharing of risks and benefits. Key partnership players include communities, national authorities and health systems, research organizations, academic centers, non-governmental organizations (NGOs), pharmaceutical companies, international funders, policymakers, and the World Health Organization (WHO). The greatest strength of these partnerships is their ability to combine the complementary strengths of different stakeholders to achieve common objectives. To improve pandemic preparedness and the capacity for prompt responses to emerging infectious diseases, the chapter recommends enhancing partnerships, embedding international R&D efforts into national health systems; providing appropriate research funding; developing and strengthening human resources, communication, infrastructures, and surveillance; and translating science into policy decisions.

More information Original publication

DOI

10.1007/978-3-031-48408-7_43

Type

Chapter

Publisher

Springer International Publishing

Publication Date

2024-01-01T00:00:00+00:00

Pages

779 - 800

Total pages

21